<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>03356cam a2200349 a 4500</leader>
  <controlfield tag="003">EG-GiCUC</controlfield>
  <controlfield tag="005">20250223031406.0</controlfield>
  <controlfield tag="008">160110s2015    ua dh  f m    000 0 eng d</controlfield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">EG-GiCUC</subfield>
    <subfield code="b">eng</subfield>
    <subfield code="c">EG-GiCUC</subfield>
  </datafield>
  <datafield tag="041" ind1="0" ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="049" ind1=" " ind2=" ">
    <subfield code="a">Deposite </subfield>
  </datafield>
  <datafield tag="097" ind1=" " ind2=" ">
    <subfield code="a">Ph.D</subfield>
  </datafield>
  <datafield tag="099" ind1=" " ind2=" ">
    <subfield code="a">Cai01.08.09.Ph.D.2015.Am.C</subfield>
  </datafield>
  <datafield tag="100" ind1="0" ind2=" ">
    <subfield code="a">Amr Maher Galal</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
    <subfield code="a">Comparative study between the urodynamic effects of anti-muscarinic drugs and the possible urodynamic effects of nicorandil and carbamazepine on over active bladder induced by type-1 diabetes mellitus : </subfield>
    <subfield code="b">Experimental and clinical study  / </subfield>
    <subfield code="c">Amr Maher Galal ; Supervised Magda Zaki , Hisham Attia , Hosni Khairi</subfield>
  </datafield>
  <datafield tag="246" ind1="1" ind2="5">
    <subfield code="a">&#x62F;&#x631;&#x627;&#x633;&#x629; &#x645;&#x642;&#x627;&#x631;&#x646;&#x629; &#x628;&#x64A;&#x646; &#x62A;&#x623;&#x62B;&#x64A;&#x631;&#x627;&#x62A; &#x62F;&#x64A;&#x646;&#x627;&#x645;&#x64A;&#x643;&#x64A;&#x629; &#x627;&#x644;&#x628;&#x648;&#x644; &#x644;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629; &#x627;&#x644;&#x63A;&#x627;&#x644;&#x642;&#x629; &#x644;&#x645;&#x633;&#x62A;&#x642;&#x628;&#x644;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x627;&#x633;&#x643;&#x627;&#x631;&#x64A;&#x646; &#x648; &#x62A;&#x623;&#x62B;&#x64A;&#x631;&#x627;&#x62A; &#x62F;&#x64A;&#x646;&#x627;&#x645;&#x64A;&#x643;&#x64A;&#x629; &#x627;&#x644;&#x628;&#x648;&#x644; &#x627;&#x644;&#x645;&#x62D;&#x62A;&#x645;&#x644;&#x629; &#x644;&#x62F;&#x648;&#x627;&#x626;&#x64A;  &#x627;&#x644;&#x646;&#x64A;&#x643;&#x648;&#x631;&#x627;&#x646;&#x62F;&#x64A;&#x644; &#x648; &#x627;&#x644;&#x643;&#x627;&#x631;&#x628;&#x627;&#x645;&#x627;&#x632;&#x64A;&#x628;&#x64A;&#x646; &#x641;&#x64A; &#x627;&#x644;&#x646;&#x634;&#x627;&#x637; &#x627;&#x644;&#x632;&#x627;&#x626;&#x62F; &#x644;&#x644;&#x645;&#x62B;&#x627;&#x646;&#x629; &#x627;&#x644;&#x645;&#x633;&#x62A;&#x62D;&#x62F;&#x62B; &#x628;&#x648;&#x627;&#x633;&#x637;&#x629; &#x627;&#x644;&#x646;&#x648;&#x639; &#x627;&#x644;&#x623;&#x648;&#x644; &#x645;&#x646; &#x62F;&#x627;&#x621; &#x627;&#x644;&#x633;&#x643;&#x631;&#x64A; : </subfield>
    <subfield code="b">&#x62F;&#x631;&#x627;&#x633;&#x629; &#x62A;&#x62C;&#x631;&#x64A;&#x628;&#x64A;&#x629; &#x648; &#x633;&#x631;&#x64A;&#x631;&#x64A;&#x629;</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="a">Cairo : </subfield>
    <subfield code="b">Amr Maher Galal , </subfield>
    <subfield code="c">2015</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">147 P. : </subfield>
    <subfield code="b">charts , facsimiles ; </subfield>
    <subfield code="c">25cm</subfield>
  </datafield>
  <datafield tag="502" ind1=" " ind2=" ">
    <subfield code="a">Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Background: Overactive bladder (OAB) is a common clinical problem. Materials and methods: Experimental study: seventy two adult male albino rats weighing 250-300 g, were classified into six groups. Blood glucose, cystometry, dose concentration response to Ach and histopathological examination were done.Clinical Study: The study was conducted on fifty with type-1 diabetes mellitus and over active bladder divided into five groups. Urodynamic studies were done and voiding diary and lower urinary symptom sheet was collected from each patient before and after treatment.  Results: Experimental findings: Diabetic rats exhibited a significant increase in the intravesical pressures, in tonic contractions to submaximal dose of ACh. and in bladder weight/body weight ratio and musculosa thickness  compared to control group, while a significant reduction in those parameters were found in diabetic treated groups to diabetic group. For bladder volume, Oxybutinin and Tolterodine showed significant decrease while Nicorandil and Carbamazepine groups showed significant increase. Clinical findings: in Oxybutinin, Tolterodine groups urodynamic parameters and bladder capacities were significantly changed compared to placebo group while insignificant change were found in Nicorandil and Carbamazepine groups. Conclusion:Carbamazepine and Nicorandil potentially suppress the overactive bladder resulted from diabetes as shown in experimental work. On the other hand the clinical study didn't show a significant role for both drugs which needs further clinical trials with a more objective investigation</subfield>
  </datafield>
  <datafield tag="530" ind1=" " ind2=" ">
    <subfield code="a">Issued also as CD</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2="4">
    <subfield code="a">Diabetes</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2="4">
    <subfield code="a">Overactive bladder</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2="4">
    <subfield code="a">Pregabalin</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2=" ">
    <subfield code="a">Hisham Attia , </subfield>
    <subfield code="e">Supervisor</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2=" ">
    <subfield code="a">Hosni Khairi , </subfield>
    <subfield code="e">Supervisor</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2=" ">
    <subfield code="a">Magda Zaki , </subfield>
    <subfield code="e">Supervisor</subfield>
  </datafield>
  <datafield tag="856" ind1=" " ind2=" ">
    <subfield code="u">http://172.23.153.220/th.pdf</subfield>
  </datafield>
  <datafield tag="905" ind1=" " ind2=" ">
    <subfield code="a">Enas</subfield>
    <subfield code="e">Cataloger</subfield>
  </datafield>
  <datafield tag="905" ind1=" " ind2=" ">
    <subfield code="a">Nazla</subfield>
    <subfield code="e">Revisor</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="2">ddc</subfield>
    <subfield code="c">TH</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">54363</subfield>
    <subfield code="d">54363</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="2">ddc</subfield>
    <subfield code="7">0</subfield>
    <subfield code="a">CUCL</subfield>
    <subfield code="b">cl210</subfield>
    <subfield code="d">2024-02-11</subfield>
    <subfield code="o">Cai01.08.09.Ph.D.2015.Am.C</subfield>
    <subfield code="p">01010110067387000</subfield>
    <subfield code="r">2023-09-22 00:00:00</subfield>
    <subfield code="y">TH</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="2">ddc</subfield>
    <subfield code="7">0</subfield>
    <subfield code="a">CUCL</subfield>
    <subfield code="b">cl2u8</subfield>
    <subfield code="d">2024-02-11</subfield>
    <subfield code="o">Cai01.08.09.Ph.D.2015.Am.C</subfield>
    <subfield code="p">01020110067387000</subfield>
    <subfield code="r">2023-09-22 00:00:00</subfield>
    <subfield code="t">67387.CD </subfield>
    <subfield code="y">CD</subfield>
  </datafield>
</record>
